Zephyr Endobronchial Valves Study Yields Positive 6 Month Data

Zephyr Endobronchial Valves Study Yields Positive 6 Month Data

Positive six-month results have emerged from a multicenter, multinational, randomized clinical trial (RCT) of the Pulmonx® Zephyr® Endobronchial Valve (EBV®). The American Journal of Respiratory and Critical Care Medicine has published the recent data from the TRANSFORM trial into Zephyr...

Latest News

Cardiology

Sentry Vena Cava Filter Yields Zero Pumonary Embolisms at 12 Months

Newly presented study findings offer support for Novate Medical's Sentry IVC filter. The SENTRY...

read the full article >

First-in-Human Use of ProtEmbo® Cerebral Protection System in EU Trial

German device company Protembis GmbH, tells us about the first clinical applications of its...

read the full article >

Approvals / Clearance

U.S. 510(K) Clearance for Adherium's Smartinhaler for AstraZeneca’s Symbicort Aerosol

The U.S. FDA has cleared Adherium's new SmartTouch for Symbicort® inhaler monitoring device for...

read the full article >

FDA Clears COALESCE™ Porous PEEK Lumbar Interbody Fusion Device

Vertera Spine's COALESCE™ Lumbar Interbody Fusion Device has been cleared by the U.S. FDA for use...

read the full article >

FDA Clearance for "Game Changing" Cardiologs ECG Analysis Platform

Cardiologs Technologies SAS has received FDA clearance of its Cardiologs ECG Analysis Platform, a...

read the full article >

Clinical Studies / Trials